Open Access. Powered by Scholars. Published by Universities.®
Pharmacy Administration, Policy and Regulation Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Chapman University (8)
- Population Council (4)
- West Virginia University (4)
- University of Kentucky (3)
- Roseman University of Health Sciences (2)
-
- Seton Hall University (2)
- University of Nebraska Medical Center (2)
- Virginia Commonwealth University (2)
- Advocate Health - Midwest (1)
- Aga Khan University (1)
- Beirut Arab University (1)
- Dartmouth College (1)
- Duquesne University (1)
- Northern Illinois University (1)
- Rowan University (1)
- University of Connecticut (1)
- University of Louisville (1)
- University of Mississippi (1)
- University of Nebraska at Omaha (1)
- University of South Carolina (1)
- University of Tennessee Health Science Center (1)
- University of Texas Rio Grande Valley (1)
- Keyword
-
- English (4)
- Economic burden (3)
- Pharmacist (3)
- Cancer (2)
- Cost-effectiveness (2)
-
- Healthcare cost (2)
- ICER (2)
- Multi-Purpose Technologies (2)
- Opioids (2)
- Pharmacists (2)
- Pharmacy (2)
- ACER (1)
- Abdominal Pain (1)
- Access to care (1)
- Air Pollution (1)
- Ambulatory care (1)
- Analgesics, Opioid (1)
- Annual wellness Visit (1)
- Antibiotic stewardship (1)
- Antimicrobial resistance (1)
- Antipsychotics (1)
- Antiretroviral Therapy/Treatment (1)
- Area-based socioeconomic measures (ABSMs) (1)
- Asthma COPD Overlap (1)
- Autoimmune diseases (1)
- Barriers (1)
- Bisphosphonate (1)
- Black Carbon (1)
- Budget impact analysis (1)
- Cancer survivorship (1)
- Publication Year
- Publication
-
- Pharmacy Faculty Articles and Research (6)
- Graduate Theses, Dissertations, and Problem Reports (ETD) (4)
- HIV and AIDS (4)
- Annual Research Symposium (2)
- Electronic Theses and Dissertations (2)
-
- Seton Hall University Dissertations and Theses (ETDs) (2)
- Theses and Dissertations (2)
- Applied Research Projects (1)
- BAU Journal - Health and Wellbeing (1)
- CORE Research Briefs (1)
- CURE Proceedings (1)
- Center for Health Services Research Faculty Publications (1)
- Community Health Sciences (1)
- Dartmouth College Ph.D Dissertations (1)
- EMET Projects (1)
- Honors Theses (1)
- Journal for Evidence-based Practice in Correctional Health (1)
- Journal of Patient-Centered Research and Reviews (1)
- MD Honors Theses (1)
- MPA/MPP/MPFM Capstone Projects (1)
- Pharmaceutical Sciences (MS) Theses (1)
- Pharmaceutical Sciences (PhD) Dissertations (1)
- Research Symposium (1)
- Rowan-Virtua Research Day (1)
- Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.) (1)
- UNO Student Research and Creative Activity Fair (1)
- Publication Type
- File Type
Articles 31 - 41 of 41
Full-Text Articles in Pharmacy Administration, Policy and Regulation
Utilizing Three Years Of Epidemiological Data From Medical Missions In Cambodia To Shape The Mobile Medical Clinic Formulary, Jeany Kim Jun, Junia S. Koo, Amy Y. Kang, Deborah B. Chien, Albert Shim, Dale Knutson, Eda M. Kim
Utilizing Three Years Of Epidemiological Data From Medical Missions In Cambodia To Shape The Mobile Medical Clinic Formulary, Jeany Kim Jun, Junia S. Koo, Amy Y. Kang, Deborah B. Chien, Albert Shim, Dale Knutson, Eda M. Kim
Pharmacy Faculty Articles and Research
Objective: The purpose of this project was to gather epidemiological data on common diseases and medications dispensed during medical mission teams to Cambodia to shape the mobile medical clinic formulary.
Methods: Data for patients seen during week-long, mobile, medical clinics was collected in Cambodia during Septembers 2012 to 2014. Patient’s gender, age, weight, blood pressure, glucose, pertinent laboratory values, diagnoses, and medications dispensed were collected. Blood pressure and glucose were measured in patients 18 years and above. Data collected onto paper intake forms were transferred onto spreadsheets without patient identifying information and analyzed for aggregate means, common diseases, and most …
Burden Of Illness And Pharmacoeconomic Evaluation Of Lumacaftor/Ivacaftor In Cystic Fibrosis, Pratyusha Vadagam
Burden Of Illness And Pharmacoeconomic Evaluation Of Lumacaftor/Ivacaftor In Cystic Fibrosis, Pratyusha Vadagam
Electronic Theses and Dissertations
Objectives: (1) To estimate the burden of illness in cystic fibrosis (CF) using 2010-2014 Medical Expenditure Panel Survey (MEPS) data, and (2) to conduct a pharmacoeconomic evaluation of lumacaftor/ivacaftor in the treatment of CF.
Methods: The study was conducted in two parts. Part 1 involved a retrospective analysis using individuals in MEPS database with an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis code of 277.00 for a principal diagnosis of CF. Dependent variables were cumulative and out-of-pocket (OOP) expenditures and independent variables included patient demographics and clinical characteristics. Unweighted and weighted estimates of expenditure in CF group, …
Research Proposal: Emrs Changing Patient Medication Errors, Kerry Moore
Research Proposal: Emrs Changing Patient Medication Errors, Kerry Moore
Applied Research Projects
In 2009 the federal government initiated the American Recovery and Reinvestment Act (ARRA) in efforts to improve timely and quality health care. This new initiative promised to provide great incentives to health care providers who took advantage of the program by implementing electronic medical records (EMRs) within their facilities, clinics, and practices. Coupled with tight deadlines and the incentive of reimbursement, the health care world has been witness to an influx of EMRs being developed by vendors and implemented at health care facilities. The rate at which these EMRs have been implemented has been astounding. So fast, the health care …
Bridging The Location Gap: Physician Perspectives Of Physician-Pharmacist Collaboration In Patient Care (Bridge Phase Ii), Keri D. Hager, Donald Uden, Daniel M. Tomaszewski
Bridging The Location Gap: Physician Perspectives Of Physician-Pharmacist Collaboration In Patient Care (Bridge Phase Ii), Keri D. Hager, Donald Uden, Daniel M. Tomaszewski
Pharmacy Faculty Articles and Research
Background: To optimize patient outcomes, the patient-centred medical home model emphasizes comprehensive team-based care. Pharmacists are qualified to enhance appropriate medication use and help improve patient outcomes through provision of medication therapy management (MTM) services. To optimally provide MTM, pharmacists must effectively collaborate with physicians. This study explored factors that influence pharmacist-physician collaboration.
Methods and Findings: A convenience sample of five physicians participated in semi-structured interviews and the resulting data were analyzed using qualitative methods. Transcripts of the interviews were independently coded for themes by two researchers. Five themes emerged: trustworthiness, role specification, relationship initiation, effects on practice, …
Applying The Pharmacists’ Patient Care Process To Immunization Services: A Resource Guide For Pharmacists, Albert Bach, Jeff Goad, Mitchel Rothholz, Brian Wall, Anne Burns, Liza Chapman, Jean-Venable “Kelly” R. Goode, Sheila Seed, Rebecca Snead
Applying The Pharmacists’ Patient Care Process To Immunization Services: A Resource Guide For Pharmacists, Albert Bach, Jeff Goad, Mitchel Rothholz, Brian Wall, Anne Burns, Liza Chapman, Jean-Venable “Kelly” R. Goode, Sheila Seed, Rebecca Snead
Pharmacy Faculty Articles and Research
"This guidance document has been written and formatted to align comprehensive components of a pharmacy-based immunization patient encounter Collect Assess Plan Implement Follow-Up 6 American Pharmacists Association and recommendations from the National Vaccine Advisory Committee (NVAC) the Standards for Adult Immunization Practice with the original framework of the PPCP.5 The colored columns to the right throughout this document are the PPCP steps as they have been published by JCPP, and the main document text describes how to integrate each PPCP step into immunization services."
Access To Essential Medicines In Pakistan: Policy And Health Systems Research Concerns., Shehla Zaidi, Maryam Bigdeli, Noureen Aleem, Arash Rashidian
Access To Essential Medicines In Pakistan: Policy And Health Systems Research Concerns., Shehla Zaidi, Maryam Bigdeli, Noureen Aleem, Arash Rashidian
Community Health Sciences
NTRODUCTION:
Inadequate access to essential medicines is a common issue within developing countries. Policy response is constrained, amongst other factors, by a dearth of in-depth country level evidence. We share here i) gaps related to access to essential medicine in Pakistan; and ii) prioritization of emerging policy and research concerns.
METHODS:
An exploratory research was carried out using a health systems perspective and applying the WHO Framework for Equitable Access to Essential Medicine. Methods involved key informant interviews with policy makers, providers, industry, NGOs, experts and development partners, review of published and grey literature, and consultative prioritization in stakeholder's Roundtable. …
Nonclinical Development Needs And Regulatory Requirements For Multipurpose Prevention Technologies: A Primer, Joseph W. Romano, Martha Brady, Judy Manning
Nonclinical Development Needs And Regulatory Requirements For Multipurpose Prevention Technologies: A Primer, Joseph W. Romano, Martha Brady, Judy Manning
HIV and AIDS
This summary outlines key development elements that will be necessary for various configurations of multipurpose prevention products for the simultaneous prevention of HIV, sexually transmitted infections, and/or pregnancy.
Shaping The Operations Research Agenda For Antiretroviral-Based Prevention Products For Women: Gels And Rings, Martha Brady, C. Elizabeth Mcgrory
Shaping The Operations Research Agenda For Antiretroviral-Based Prevention Products For Women: Gels And Rings, Martha Brady, C. Elizabeth Mcgrory
HIV and AIDS
This report summarizes discussions from a two-day international experts consultation meeting in 2012 on preparing for the successful introduction of women-centered antiretroviral-based HIV prevention methods. It examines the limits and expectations of operations research in antiretroviral health technologies.
Facilitating Regulatory Approval Of Multipurpose Prevention Technologies For Sexual And Reproductive Health, Martha Brady
Facilitating Regulatory Approval Of Multipurpose Prevention Technologies For Sexual And Reproductive Health, Martha Brady
HIV and AIDS
This brief describes multipurpose prevention technologies (MPTs) that address women's sexual and reproductive health (SRH) needs, and how to go about facilitating regulatory approval of this technology. It outlines a strategic framework to examine current regulatory guidance, as well a product development pathway to bring MPTs to market.
Constructing A Critical Path For Product Development, Commercialization, And Access, Martha Brady
Constructing A Critical Path For Product Development, Commercialization, And Access, Martha Brady
HIV and AIDS
This brief discusses the Council's health technologies development and the product development path from conceptualization to market. It defines the steps in the Critical Path Framework, and examines activities at the preclinical and clinical stage.
Retirees And Pharmaceutical Costs: Is There Really A Crisis?, Justine Maiello
Retirees And Pharmaceutical Costs: Is There Really A Crisis?, Justine Maiello
Seton Hall University Dissertations and Theses (ETDs)
.